By devising special pixels, Stanford University researchers have enhanced prosthetic vision with a new implant that improves vision.
A Stanford patient improved greatly after being the first person with sight-threatening thyroid eye disease to receive the drug teprotumumab.
Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.
The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.
A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.
Stanford Medicine researcher John Ioannidis calls for transparency and the sharing of data, a lesson learned through COVID-19.
Stanford infectious disease expert Yvonne Maldonado, MD, describes principles for developing safe and effective COVID-19 vaccines for everyone.
Many early clinical studies of COVID-19 fail to meet quality standards, raising concerns that the data could be of little meaningful use, research finds.
Researchers at Stanford are mining millions of de-identified patient records using machine learning to determine long-term safety of medical devices.
At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.
A new Stanford study in children with autism showed the value of teaching parents how to use everyday interactions to motivate their children to speak.
A therapy delayed the onset of Type 1 diabetes in at-risk people by about two years, new results from a clinical trial show.
An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
Orthopaedic surgeon Constance Chu has spent her career seeking ways to prevent osteoarthritis from developing after a knee injury.
